Assistive Technologies for ALS

This trial aims to develop a new tool to measure how well assistive technologies (ATs) and brain-computer interfaces (BCIs) help people with severe motor impairments use digital devices independently. Participants will test various devices, such as eye trackers and mouth-operated joysticks, to assess their effectiveness in performing digital tasks. The study will focus on individuals with amyotrophic lateral sclerosis (ALS) or spinal cord injuries (SCI) who can communicate and participate in a study session for up to three hours. Researchers will use the Digital Assessment Interface (DAI) to evaluate these technologies. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance digital independence for individuals with severe motor impairments.

The trial information does not specify whether you need to stop taking your current medications. It only mentions that participation in another conflicting trial is not allowed.

Research has shown that assistive technologies (ATs) and brain-computer interfaces (BCIs) are generally well-tolerated by people with severe movement difficulties. A review of ATs indicates that these tools are safe and helpful for those with neurological disabilities. Common tools like eye trackers and mouth-operated joysticks assist users in communicating and interacting with digital devices. Studies have found these tools to be safe and free from major side effects.

For brain-computer interfaces, research on non-invasive options like EEG headsets (which monitor brain activity) has shown they are safe. People using these devices have not reported serious negative effects. Individuals with conditions like ALS (amyotrophic lateral sclerosis) often use them to aid communication.

Researchers are excited about the Digital Assessment Interface (DAI) for ALS because it integrates advanced assistive technologies like eye trackers, mouth-operated joysticks, and non-invasive EEG headsets. Unlike traditional methods that focus on symptom management, DAI aims to enhance communication and interaction for individuals with ALS by using brain-computer interfaces that can better adapt to each user's needs. This personalized approach could significantly improve the quality of life for patients by allowing more intuitive control over their environment.

Research has shown that assistive technologies (ATs) and brain-computer interfaces (BCIs) can help people with ALS (a disease that weakens muscles) use digital devices more independently. In this trial, participants in the AT/BCI User arm will undergo training and digital assessment using various assistive technologies, including eye trackers, mouth-operated joysticks, and non-invasive EEG headsets. Eye-tracking devices, for example, enable individuals with limited movement to control computers by moving their eyes. Studies have found that BCIs, which read brain signals, can also help users manage digital systems effectively. Direct comparisons of eye trackers and BCIs show promise in assisting ALS patients. Overall, these technologies can ease the use of digital devices for people with severe movement difficulties.¹⁶⁷⁸⁹